Latest filing published 26 Feb 2026 for Vir Biotechnology, Inc., €13k.
Filing timeline
BuySaleInsider track record
Mark Eisner: trading record in brief
Mark Eisner, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Kyntra Bio, Inc. and Vir Biotechnology, Inc. We count 24 filings; the first trade dates from 1 December 2020 and the latest from 24 February 2026.
Every open-market trade on record is a sale: 7 sales worth €426k. The rest of the record consists of 17 share grants. In 2026 alone, the filings show no purchases and 1 sale.
The record was last updated on 26 February 2026 with an open-market sale (€13k) in Vir Biotechnology, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark Eisner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,616 shares@ US$9.53260.0010% mcap29.0% of flowCommon StockSEC:0001628280-26-012394:0
- 55,000 shares0Common StockSEC:0001628280-26-011329:0
- 6,796 shares@ US$5.468271.0% of flowCommon StockSEC:0001628280-25-035269:0
- 40,000 shares0Common StockSEC:0001628280-25-007699:0
- 75,000 shares0Common StockSEC:0000950170-24-083951:0
- 1,860 shares@ US$0.96310.2% of flowCommon StockSEC:0001209191-23-048809:0
- 1,085 shares@ US$1.060.1% of flowCommon StockSEC:0001209191-23-048555:0
- 2,042 shares@ US$17.0384.5% of flowCommon StockSEC:0001209191-23-036054:0
- 1,090 shares@ US$18.832.6% of flowCommon StockSEC:0001209191-23-034288:0
- 9,182 shares@ US$18.783821.6% of flowCommon StockSEC:0001209191-23-023592:0
- 7,363 shares@ US$21.155920.3% of flowCommon StockSEC:0001209191-23-018063:0
- 1,187 shares@ US$21.873.3% of flowCommon StockSEC:0001209191-23-016362:0
- 32,500 shares0Common StockSEC:0001209191-23-012425:0
- 1,084 shares@ US$15.042.1% of flowCommon StockSEC:0001209191-22-059472:0
- 6,777 shares@ US$13.0112.3% of flowCommon StockSEC:0001209191-22-052381:0
- 756 shares@ US$13.091.4% of flowCommon StockSEC:0001209191-22-048555:0
- 1,141 shares@ US$9.611.4% of flowCommon StockSEC:0001209191-22-034041:0
- 6,442 shares@ US$12.029.6% of flowCommon StockSEC:0001209191-22-022095:0
- 756 shares@ US$13.621.3% of flowCommon StockSEC:0001209191-22-015366:0
- 60,000 shares0Common StockSEC:0001209191-22-010452:0
- 7,043 shares@ US$14.8212.6% of flowCommon StockSEC:0001209191-22-001743:0
- 4,338 shares@ US$12.656.6% of flowCommon StockSEC:0001209191-21-067780:0
- 74,520 shares0Common StockSEC:0001209191-21-059869:0
- 35,000 shares0Common StockSEC:0001209191-20-061651:0
24 of 24 declarations
